Ovation Science announces a proposed private placement offering of up to 4,000,000 units (each a “Unit”) at a price of $0.42 per Unit for total proceeds of up to $1,680,000 (the “Offering”).

Ovation Science has signed a distribution agreement for its DermSafe® hand sanitizer with Gad Medical Equipment Ltd. (Gad Medical) for Israel.

Ovation Science announces its President, Mr. Terry Howlett will be presenting at Adelaide Capital’s Virtual COVID & Healthcare Mini Conference

Ovation Science is enjoying a record first quarter which will continue to add shareholder value. The extraordinary opportunity to help fight the coronavirus (Covid-19) pandemic globally is boosting revenues and the Company expects to enjoy several consecutive record quarters.

Due to the seriousness and virulence of the COVID-19 virus, Ovation Science has seen heightened demand for its long-lasting chlorhexidine gluconate hand sanitizing lotion called DermSafe.

Тhe interest foр DermSafe® hand sanitizer lotion has gone worldwide. In addition to the shipment to China, the Company has shipped thousands of bottles to the UK as well as receiving multiple orders from Canada.

The Canadian Football League (CFL) has ordered Ovation’s DermSafe® hand sanitizer lotion for its upcoming CFL scouting combines for prospects hoping to be drafted later this Spring.

Ovation Science Inc. has shipped the first order of its DermSafe® hand sanitizer lotion to China. This follows the recent announcement on February 13th of receiving the order and full payment for 25,000 units of DermSafe.

Ovation Science Inc. announced that it has filed a provisional patent with the U.S. Patent and Trademark Office (USPTO) for its highly effective transdermal delivery of cannabinoids CBD and THC.

Ovation Science Inc. announces it has received an initial purchase order and full payment for 25,000 units of its DermSafe® hand sanitizer lotion made with chlorhexidine gluconate; an ingredient proven to be effective at killing both bacteria and viruses.